EP02.01. SOX2 Deregulated Squamous Carcinomas Are Vulnerable to AKT3 Inhibition - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Wenrui Guo
Meta Tag
Speaker Wenrui Guo
Topic Tumor Biology: Preclinical Biology - Molecular Therapeutic Targets
University of Cambridge
in vitro organotypic model
squamous cell lung cancer
AKT3 inhibition
biomarker-driven clinical trial
chemopreventive efficacy
PI3K inhibition
colony formation capacity
targeted therapy
Powered By